Saturday 17 October 2026 Export ABCL’s income statement to Excel — free account

AbCellera Biologics Inc.

AbCellera Biologics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.1 million, up 160.6% from fiscal 2024. In the quarter to June 2026, revenue fell 76.3%, EPS fell 50.0% and free cash flow grew 152.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

11.80 0.88 −6.94%

Follow ABCL

Alert me

Market cap: $4.1B
P/E: 0.0×
Fwd P/E: −8.7×
Dividend yield: —
F-score: 5/9
Altman Z: 1.66
Beneish M: −1.06
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		42.56	13.60	13.35	36.25
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(28.58)	(29.40)	(31.55)	92.53
P/B ratio Full definition →		1.56	1.06	1.13	2.68
Price to Tangible BV Full definition →		1.71	1.16	1.24	2.96
EV/Sales Full definition →		27.92	6.21	6.71	27.76
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(9.43)	(3.55)	(3.47)	(19.35)
EV/FCF Full definition →		(6.31)	(2.63)	(2.76)	(14.96)
Quick Ratio Full definition →		8.17	9.60	11.98	10.97
Current Ratio Full definition →		10.10	11.32	14.05	12.77
Net Debt/EBITDA Full definition →		7.54	27.05	10.84	10.47
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.03	0.06	0.06	0.05
Operating CF/Net income Full definition →		0.92	3.88	0.78	(0.47)
Capex/Depreciation Full definition →		(1.23)	(1.24)	(0.44)	(0.24)
Research and Development Expense of Revenue Full definition →		614.49%	111.68%	561.18%	1,135.48%
Selling, General and Administrative Expense of Revenue Full definition →		278.70%	38.39%	148.33%	341.98%
Intangible Assets out of Total Assets Full definition →		0.06	0.06	0.07	0.06
Share Based Compensation of Revenue Full definition →		155.16%	28.77%	144.47%	303.36%
Graham Net Nets Full definition →		0.20	0.33	0.28	0.11
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(11.33%)	(14.33%)	(13.75%)	(6.88%)
Free Cash Flow Yield Full definition →		(10.39%)	(17.34%)	(18.19%)	(5.12%)
Revenue per Share Full definition →		0.03	0.15	0.03	0.01
Operating CF per Share Full definition →		(0.18)	(0.12)	(0.11)	0.08
Capex per Share Full definition →		(0.03)	(0.03)	(0.01)	(0.01)
Free Cash Flow per Share Full definition →		(0.21)	(0.15)	(0.12)	0.08
Cash per Share Full definition →		1.74	1.87	1.75	1.85
Shareholders Equity per Share Full definition →		3.23	3.24	3.10	2.93
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		3.23	3.24	3.10	2.93
Free Cash Flow Full definition →		(61.52)	(44.59)	(37.35)	23.79
Working Capital Full definition →		626.34	663.93	617.30	626.04
Capital Expenditures Full definition →		(8.93)	(9.84)	(3.83)	(2.13)
Net Current Asset Value Full definition →		303.19	338.19	295.57	267.68
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		1.00	0.22	0.46	0.53
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		36.41	45.95	38.38	32.95
Average Payables Full definition →		53.45	52.89	43.70	41.28
Average Assets Full definition →		1,374.41	1,358.75	1,325.66	1,354.82
Average Common Equity Full definition →		1,021.07	1,011.49	980.53	951.55

Show all line items

Columns are period end dates

Stockrow Weekly